Matrix Metalloproteinases: Discrete Elevations in Essential Hypertension and Hypertensive End-Stage Renal Disease

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical and experimental hypertension

• Publication date

  2009-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10641960802668730PMID 19886850PMCID PMC2875383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteinase Activity and Receptor Cleavage: Mechanism for Insulin Resistance in the Spontaneously Hypertensive Rat

  2008cited by this paper
• Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

  2008influential reference
• ACE inhibitors to block MMP-9 activity: new functions for old inhibitors.

  2007cited by this paper
• The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix Metalloproteinases

  2007cited by this paper
• Matrix metalloproteinases: useful and deleterious.

  2007cited by this paper
• Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension

  2007cited by this paper
• Impact of the Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 System on Large Arterial Stiffness in Patients with Essential Hypertension

  2007cited by this paper
• Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients.

  2007cited by this paper
• Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases: Relationship Between Changes in Proteolytic Determinants of Matrix Composition and Structural, Functional, and Clinical Manifestations of Hypertensive Heart Disease

  2006cited by this paper
• Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.

  2006cited by this paper
• Increased levels of atherosclerosis markers in salt-sensitive hypertension.

  2006cited by this paper
• Role of angiotensin II receptor blockers in atherosclerotic plaque stability

  2006cited by this paper
• Is hypertension an inflammatory process?

  2006cited by this paper
• Changes in metalloproteinases in healthy normotensive patients with high-normal blood pressure.

  2005cited by this paper
• The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension.

  2004influential reference
• Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment

  2003cited by this paper
• Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors.

  2002cited by this paper
• Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells.

  2001cited by this paper
• Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy.

  2000cited by this paper
• Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

  1999cited by this paper
• Abnormalities of the extracellular degradation of collagen type I in essential hypertension.

  1998cited by this paper

• Metalloproteinases (MMPs) in hypertensive disorders: role, function, pharmacology, and potential strategies to mitigate pathophysiological changes

  2025cites this paper
• Computational Insights into Captopril’s Inhibitory Potential Against MMP9 and LCN2 in Bladder Cancer: Implications for Therapeutic Application

  2024cites this paper
• Association of matrix metalloproteinase‐2 gene variants with diabetic nephropathy risk

  2023cites this paper
• Matrix Metalloproteinase-10 in Kidney Injury Repair and Disease

  2022cites this paper
• Mechanisms underlying the effects of caloric restriction on hypertension.

  2022cites this paper
• Association of Hypertension and Organ-Specific Cancer: A Meta-Analysis

  2022cites this paper
• Evaluation of MMP-9 with atherogenic index and electrocardiogram as a predictor of cardiovascular risk factors in hypertensive patients

  2022cites this paper
• Identification of novel therapeutic targets for contrast induced acute kidney injury (CI-AKI): alpha blockers as a therapeutic strategy for CI-AKI.

  2021cites this paper
• Therapeutic enzymes as non-conventional targets in cardiovascular impairments:A Comprehensive Review.

  2021cites this paper
• Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease.

  2021cites this paper
• Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis

  2020cites this paper
• Matrix metalloproteinase-9 as a messenger in the cross talk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review

  2020cites this paper
• Matrix Metalloproteinases and Hypertension-Mediated Organ Damage: Current Insights

  2020cites this paper
• Suppression of β1-Adrenoceptor Autoantibodies is Involved in the Antiarrhythmic Effects of Omega-3 Fatty Acids in Male and Female Hypertensive Rats

  2020cites this paper
• Primary African American Endothelial Cells Exhibit Endothelial Dysfunction with an Exacerbated Inflammatory Profile and Blunted MMP-2 Activity

  2020cites this paper
• Vitamin D levels correlate with Metabolic Syndrome Criteria in Algerian Patients: The Ex-vivo Immuomodulatory Effect of α, 25 Dihydroxyvitamin D3.

  2020cites this paper
• Pancreatic source of protease activity in the spontaneously hypertensive rat and its reduction during temporary food restriction

  2019cites this paper
• Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal

  2019cites this paper
• The effect of endurance training along with L-arginine supplementation on the levels of MMP-2 and MMP-9 in postmenopausal hypertensive women

  2019cites this paper
• Role of Magnesium Deficiency in Promoting Atherosclerosis, Endothelial Dysfunction, and Arterial Stiffening as Risk Factors for Hypertension

  2018cites this paper
• The role of some oxidative stress and inflammatory factors in essential hypertension

  2018cites this paper
• Matrix metalloproteinase‐9, 10, and stress hyperglycaemia in acute kidney injury

  2018cites this paper
• Feature selection and classification of urinary mRNA microarray data by iterative random forest to diagnose renal fibrosis: a two-stage study

  2017cites this paper
• Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay

  2017cites this paper
• Atherothrombosis as a Leading Cause of Acute Coronary Syndromes and Stroke: The Main Killers in Developed Countries

  2017influential citation
• MicroRNA-mediated MMP Regulation: Current Diagnostic and Therapeutic Strategies for Metabolic Syndrome.

  2017cites this paper
• Precision Medicine in Cardiovascular Diseases

  2017cites this paper
• Extracellular overhydration linked with endothelial dysfunction in the context of inflammation in haemodialysis dependent chronic kidney disease

  2017cites this paper
• Matrix Metalloproteases in Arterial Hypertension and their Trend after Antihypertensive Treatment

  2017cites this paper
• MMP-2 serum concentrations predict mortality in hemodialysis patients: a 5-year cohort study.

  2016cites this paper
• Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review

  2016cites this paper
• Personalized Proteomics: The Future of Precision Medicine.

  2016cites this paper
• Development and Application of Gadolinium Free Cardiac Magnetic Resonance Fibrosis Imaging for Multiscale Study of Heart Failure in Patients with End Stage Renal Disease

  2016cites this paper
• Personalized Proteomics: The Future of Precision Medicine

  2016cites this paper
• Abnormal Circulating Levels of Metalloproteinase and Their Inhibitor in Hypertensive Patients.

  2016cites this paper
• Decreases in plasma MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in uremic patients during hemodialysis

  2016cites this paper
• Matrix Metalloproteinase (MMP)-9 Levels in Children on Hemodialysis: Association with MMP-9 C-1562T Gene Polymorphism and Vitamin D Levels

  2016cites this paper
• The Discovery of Novel Genomic, Transcriptomic, and Proteomic Biomarkers in Cardiovascular and Peripheral Vascular Disease: The State of the Art

  2016cites this paper
• Serum Concentrations of Endothelin-1 and Matrix Metalloproteinases-2, -9 in Pre-Hypertensive and Hypertensive Patients with Type 2 Diabetes

  2016cites this paper
• A reduced graphene oxide-based fluorescence resonance energy transfer sensor for highly sensitive detection of matrix metalloproteinase 2

  2016cites this paper
• Matrix Metalloproteinases in Non-Neoplastic Disorders

  2016cites this paper
• Roles of Caveolin-1 in Angiotensin II–Induced Hypertrophy and Inward Remodeling of Cerebral Pial Arterioles

  2016cites this paper
• Emergence of a metalloproteinase / phospholipase A2 axis of systemic inflammation.

  2015cites this paper
• Proteolytic receptor cleavage in the pathogenesis of blood rheology and co-morbidities in metabolic syndrome. Early forms of autodigestion

  2015cites this paper
• Association of N-Terminal Pro–Brain Natriuretic Peptide, Matrix –Metalloprotinase-9, and 8-Oxo-2 Deoxy Guanosine with the Incidence of Essential Hypertension

  2015cites this paper
• Ocena stężenia metaloproteinazy 2 (MMP-2) i metaloproteinazy 9 (MMP-9) w surowicy chorych na pierwotne nadciśnienie tętnicze

  2015cites this paper
• Tailor-made peptide sensor for detection of matrix metalloproteinase 2 in blood serum

  2015cites this paper
• MMPs in Cardiovascular Diseases: Emerging Pharmacological Targets

  2014cites this paper
• Matrix Metalloproteinases and Hypertension

  2014cites this paper
• Load independent impairment of reverse remodeling after valve replacement in hypertensive aortic stenosis patients.

  2014cites this paper
• Novel 19F Activatable Probe for the Detection of Matrix Metalloprotease-2 Activity by MRI/MRS

  2014cites this paper
• ADAMTS-7 Expression Increases in the Early Stage of Angiotensin II-Induced Renal Injury in Elderly Mice

  2014cites this paper
• Effects of the use of assisted reproduction and high-caloric diet consumption on body weight and cardiovascular health of juvenile mouse offspring.

  2013influential citation
• Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHAT

  2013cites this paper
• Matrix metalloproteinase inhibition mitigates renovascular remodeling in salt-sensitive hypertension

  2013cites this paper
• Gelatinases and Their Tissue Inhibitors in a Group of Subjects With Metabolic Syndrome

  2013influential citation
• Circulating biomarkers of collagen metabolism in arterial hypertension: relevance of target organ damage

  2013cites this paper
• Biomarkers in Essential Hypertension

  2013cites this paper
• Is there any genetic predisposition of MMP-9 gene C1562T and MTHFR gene C677T polymorphisms with essential hypertension?

  2013cites this paper
• Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases.

  2013cites this paper
• Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice

  2013cites this paper
• Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels.

  2012cites this paper
• Matrix metalloproteinases in metabolic syndrome.

  2012cites this paper
• Upconversion fluorescence resonance energy transfer based biosensor for ultrasensitive detection of matrix metalloproteinase-2 in blood.

  2012cites this paper
• Myocardial structure and matrix metalloproteinases.

  2012cites this paper
• Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage Kidney Disease

  2012cites this paper
• Vascular biology of pregnancy : a study of endothelial markers in hypertension in pregnancy

  2012influential citation
• Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis

  2012cites this paper
• Detection of MMPs and their inhibitors using a whole blood protease assay

  2012cites this paper
• MMP-2 and sTNF-R1 Variability in Patients with Essential Hypertension: 1-Year Follow-Up Study

  2012cites this paper
• Circulating matrix metalloproteinases and their inhibitors in hypertension.

  2012cites this paper
• Receptor cleavage and P‐selectin‐dependent reduction of leukocyte adhesion in the spontaneously hypertensive rat

  2012cites this paper
• Matrix metalloproteinase-9, -10, and -12, MDM2 and p53 expression in mouse liver during dimethylnitrosamine-induced oxidative stress and genomic injury

  2012cites this paper
• The role of matrix metalloproteinases in essential hypertension.

  2012cites this paper
• Imbalances in the neurotrophic effects of noradrenaline, favouring the positive in the child and the negative in the mother, are the cause of preeclampsia.

  2012cites this paper
• An Emerging Role of Degrading Proteinases in Hypertension and the Metabolic Syndrome: Autodigestion and Receptor Cleavage

  2012influential citation
• Effect of Resistance Training on Biomarkers of Vascular Function and Oxidative Stress in Young African American and Caucasian men

  2012cites this paper
• Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target.

  2012cites this paper
• Insights into the Activity, Differential Expression, Mutual Regulation, and Functions of Matrix Metalloproteinases and A Disintegrin and Metalloproteinases in Hypertension and Cardiac Disease

  2012cites this paper
• Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes

  2012cites this paper
• 25-hydroxyvitamin D concentration is inversely associated with serum MMP-9 in a cross-sectional study of African American ESRD patients

  2011cites this paper
• Consistent alterations of circulating matrix metalloproteinases levels in untreated hypertensives and in spontaneously hypertensive rats: a relevant pharmacological target.

  2011cites this paper
• Matrix metalloproteinases and small artery remodeling.

  2011cites this paper
• Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis.

  2011cites this paper
• Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases.

  2011cites this paper
• [Chronic inflammation in patients with acute coronary syndrome and chronic kidney disease].

  2011cites this paper
• THE AUTODIGESTION HYPOTHESIS AND RECEPTOR CLEAVAGE IN DIABETES AND HYPERTENSION.

  2011cites this paper
• Receptor cleavage reduces the fluid shear response in neutrophils of the spontaneously hypertensive rat.

  2010cites this paper
• Effects of hypertension, acute and long-term exercise on pseudopod formation on naïve neutrophils and plasma matrix metalloproteinase levels and activity

  2010influential citation
• Influence of elastin-derived peptides on metalloprotease production in endothelial cells.

  2010cites this paper
• Whole blood assay for elastase, chymotrypsin, matrix metalloproteinase-2, and matrix metalloproteinase-9 activity.

  2010cites this paper
• Matrix Metalloproteinases and their Inhibitors in Hypertensive Cardiac Remodelling

  2010cites this paper
• Vascular receptors as new substrates for matrix metalloproteinases in hypertension and other inflammatory states.

  2010influential citation
• Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.

  2009cites this paper